P3.225 HSV-2 Seroprevalence Among Current Injection Drug Users in Estonia
Uusküla A, Raag M, Abel-Ollo K, Talu A, Rüütel K, Salekesin M, Niccolai L, White T, Heimer R. P3.225 HSV-2 Seroprevalence Among Current Injection Drug Users in Estonia. Sexually Transmitted Infections 2013, 89: a218. DOI: 10.1136/sextrans-2013-051184.0682.Peer-Reviewed Original ResearchHSV-2 seroprevalenceDrug usersHSV-2 antibody testingSexual HIV transmission riskRisk behaviorsHerpes simplex virus type 2Current injection drug usersSimplex virus type 2HSV-2 seropositivityHSV-2 infectionHIV transmission riskPrevalence of HIVSexual risk reduction interventionInjection drug usersInjection risk behaviorsRisk reduction interventionsDrug use historyVirus type 2Sexual risk behaviorsHIV/AIDSRecent behavior changesHSV2 infectionSTI prevalenceActive IDUsHIV infection